{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:43:24Z","timestamp":1791859404812,"version":"4.3.4"},"reference-count":217,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Leishmaniasis is an orphan, vector-borne parasitic disease endemic in more than 90 countries. It displays different clinical manifestations, being the cutaneous form (CL) the most common. This presents as skin ulcers that produce significant psychosocial distress, lifelong scarring and stigmatization. Historically endemic in low-income regions in the tropics, epidemiological data and computational models forecast the continued expansion into regions further away from the Equator, both northwards and southwards. Treatments for CL are unsatisfactory and are currently the major unmet medical need for the leishmaniases. An inherent difficulty with using the available systemic drugs is that they are highly toxic and painful to administer and require second-level hospital infrastructure to manage side effects. In this context, local treatments, and in particular topical treatments for CL are particularly interesting due to their potential to be efficacious and less toxic, painful and inconvenient than systemic treatments. They could improve patient compliance and allow self-treatment, diminishing associated financial costs both for the patients and for the states that usually provide the treatments. In this work we discuss epidemiology of the disease and availability of treatments and then center on topical treatments, covering advances in preclinical and clinical studies.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1588311","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:01:31Z","timestamp":1768204891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Cutaneous leishmaniasis: epidemiology, treatment access and translational challenges of topical therapies"],"prefix":"10.3389","volume":"16","author":[{"given":"Dolores C.","family":"Carrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Papera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego N.","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"105707","DOI":"10.1016\/j.actatropica.2020.105707","article-title":"Visceral leishmaniasis in Saudi Arabia: from hundreds of cases to zero","volume":"212","author":"Abuzaid","year":"2020","journal-title":"Acta Trop."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"108554","DOI":"10.1016\/j.exppara.2023.108554","article-title":"Promising natural products for the treatment of cutaneous leishmaniasis: a review of in vitro and in vivo studies","volume":"251","author":"Afonso","year":"2023","journal-title":"Exp. Parasitol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"106325","DOI":"10.1016\/j.actatropica.2022.106325","article-title":"Topical treatment of cutaneous leishmaniasis lesions using quercetin\/Artemisia-capped silver nanoparticles ointment: modulation of inflammatory response","volume":"228","author":"Alemzadeh","year":"2022","journal-title":"Acta Trop."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.18502\/ijpa.v18i4.14241","article-title":"Field efficacy of topical Nano-liposomal amphotericin B (Sina Ampholeish\u00ae) alone or in combination with Glucantime\u00ae and cryotherapy on human cutaneous Leishmaniasis","volume":"18","author":"Alizadeh","year":"2023","journal-title":"Iran. J. Parasitol."},{"key":"ref90010","doi-asserted-by":"publisher","first-page":"e00807","DOI":"10.1128\/aac.00807-20","article-title":"Gallic and ellagic acids are promising adjuvants to conventional amphotericin B for the treatment of cutaneous leishmaniasis","volume":"64","author":"Alves","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.cytox.2020.100038","article-title":"Non-human primates and Leishmania immunity","volume":"2","author":"Andr\u00e9","year":"2020","journal-title":"Cytokine: X"},{"key":"ref7","volume-title":"Appili Therapeutics announces alignment with FDA on development requirements for ATI-1801 topical antiparasitic product NDA submission","year":"2024"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"\u2018Diagnosis and treatment of Leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)\u2018","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (Paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran","volume":"53","author":"Asilian","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and IL meglumine antimoniate (Glucantime\u00ae) vs. cryotherapy and IL meglumine antimoniate (Glucantime\u00ae) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"ref9001","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/tropicalmed9090218","article-title":"Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis","volume":"9","author":"Astman","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0005739","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis\u2014implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/icb.2010.108","article-title":"TGF-\u03b2-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters","volume":"89","author":"Banerjee","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/03639045.2021.1890768","article-title":"Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses","volume":"47","author":"Batool","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref90020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2460\/ajvr.1993.54.01.113","article-title":"Determination of virulence and pathogenesis of a canine strain of Leishmania leishmania infantum in hamsters and dogs","volume":"54","author":"Binhazim","year":"1993","journal-title":"American journal of veterinary research"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0007856","DOI":"10.1371\/journal.pntd.0007856","article-title":"Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: a cost-effectiveness analysis","volume":"13","author":"Brito","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/030098588602300310","article-title":"Experimental visceral leishmaniasis in the owl monkey","volume":"23","author":"Broderson","year":"1986","journal-title":"Vet. Pathol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/iai.73.4.2101-2108.2005","article-title":"Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions","volume":"73","author":"Buxbaum","year":"2005","journal-title":"Infect. Immun."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"116881","DOI":"10.1016\/j.biopha.2024.116881","article-title":"Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis","volume":"177","author":"Cabral","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jebm.12245","article-title":"Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis","volume":"10","author":"Cardona-Arias","year":"2017","journal-title":"J. Evid. Based Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12889-018-5060-2","article-title":"Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia","volume":"18","author":"Cardona-Arias","year":"2018","journal-title":"BMC Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e230182","DOI":"10.1590\/0074-02760230182","article-title":"FVB\/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis","volume":"119","author":"Carrara","year":"2024","journal-title":"Memorias Inst. Oswaldo Cruz"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e00132523","DOI":"10.1590\/0102-311XEN132523","article-title":"Cost-effectiveness study of therapeutic approaches for mucosal leishmaniasis","volume":"40","author":"Carvalho","year":"2024","journal-title":"Cad. Saude Publica"},{"key":"ref28","volume-title":"Clinical care for leishmaniasis","year":"2024"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0035-9203(81)90032-8","article-title":"Leishmania donovani in the owl monkey (Aotus trivirgatus)","volume":"75","author":"Chapman","year":"1981","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0009181","DOI":"10.1371\/journal.pntd.0009181","article-title":"The global procurement landscape of leishmaniasis medicines","volume":"15","author":"Choi","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4269\/ajtmh.2012.11-0717","article-title":"Case report: emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma","volume":"88","author":"Clarke","year":"2013","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00436-024-08199-w","article-title":"Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis","volume":"123","author":"Clemente","year":"2024","journal-title":"Parasitol. Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijid.2019.08.018","article-title":"Epidemiological and molecular investigation of resurgent cutaneous leishmaniasis in Sudan","volume":"88","author":"Collis","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1756-3305-7-361","article-title":"A canine model of experimental infection with Leishmania (L.) mexicana","volume":"7","author":"Cruz-Chan","year":"2014","journal-title":"Parasites Vectors"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e210402","DOI":"10.1590\/0074-02760210402","article-title":"Past and future of trypanosomatids high-throughput phenotypic screening","volume":"117","author":"Dantas","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"118900","DOI":"10.1016\/j.ijpharm.2019.118900","article-title":"Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes","volume":"573","author":"Dar","year":"","journal-title":"Int. J. Pharm."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/17425247.2020.1700227","article-title":"Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis","volume":"17","author":"Dar","year":"","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref38","volume-title":"\u2018A very cruel exit\u2019: UK\u2019S aid cuts risk rapid return of treatable diseases, the Guardian, 19 October","author":"Davies","year":"2022"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1590\/0037-8682-0133-2017","article-title":"The direct costs of treating human visceral leishmaniasis in Brazil","volume":"50","author":"de Assis","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4269\/ajtmh.21-0962","article-title":"Case report: local treatment of a Leishmania tropica infection in a Syrian child with a novel Filmogenic preparation of pharmaceutical sodium chlorite (LeiProtect\u00ae)","volume":"106","author":"Debus","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.3390\/pharmaceutics15112602","article-title":"Therapeutic activity of a topical formulation containing 8-Hydroxyquinoline for cutaneous leishmaniasis","volume":"15","author":"De Lima","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref9019","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0014-4894(86)90187-6","article-title":"Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys, Saimiri sciureus","volume":"61","author":"Dennis","year":"1986","journal-title":"Exp. Parasitol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1590\/0037-8682-0213-2016","article-title":"Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis","volume":"49","author":"de Oliveira Duque","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/s0036-46651999000200005","article-title":"Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice","volume":"41","author":"de Oliveira","year":"1999","journal-title":"Rev. Inst. Med. Tropical Sao Paulo"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e12947","DOI":"10.1111\/pim.12947","article-title":"Different inoculum of Leishmania braziliensis concentrations influence immunopathogenesis and clinical evolution in the ear dermis hamster model of cutaneous leishmaniasis","volume":"44","author":"de Paula Freire","year":"2022","journal-title":"Parasite Immunol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e23200","DOI":"10.7759\/cureus.23200","article-title":"Evaluating the efficacy of combined intralesional sodium stibogluconate plus topical imiquimod on healing and risk of scarring of cutaneous leishmaniasis: a Case-control study","volume":"14","author":"Dhaher","year":"2022","journal-title":"Cureus."},{"key":"ref47","volume-title":"Leishmaniasis East Africa platform (LEAP)","year":"2024"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0004545","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/pharmaceutics14112528","article-title":"Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis","volume":"14","author":"El-Dirany","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-f","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","volume":"27","author":"El-On","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1128\/aac.26.5.745","article-title":"Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals","volume":"26","author":"El-On","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/1523-1747.ep12696697","article-title":"Topical treatment of cutaneous leishmaniasis","volume":"87","author":"El-On","year":"1986","journal-title":"J. Invest. Dermatol."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.18502\/ijpa.v14i2.1130","article-title":"Safety evaluation of topical application of Nano-liposomal form of amphotericin B (SinaAmpholeish) on healthy volunteers; phase I clinical trial","author":"Eskandari","year":"2019","journal-title":"Iran. J. Parasitol."},{"key":"ref55","volume-title":"Cutaneous leishmaniasis: Annual epidemiological report for 2015","year":"2015"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate","volume":"28","author":"Faghihi","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"ref57","volume-title":"FDA (U.S. Food and Drug Administration) warns that oral Nizoral (ketoconazole) tablets continue to be prescribed for unapproved uses, including treating nail and skin infections; use of this drug has been linked to patient death","year":"2016"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/acsinfecdis.0c00293","article-title":"Ultradeformable lipid vesicles localize amphotericin B in the dermis for the treatment of infectious skin diseases","volume":"6","author":"Fern\u00e1ndez-Garc\u00eda","year":"2020","journal-title":"ACS Infectious Diseases"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e0012175","DOI":"10.1371\/journal.pntd.0012175","article-title":"Amphotericin B resistance in Leishmania amazonensis: in vitro and in vivo characterization of a Brazilian clinical isolate","volume":"18","author":"Ferreira","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s0014-4894(03)00099-7","article-title":"Immunological and pathological evaluation of rhesus macaques infected with Leishmania major","volume":"103","author":"Freidag","year":"2003","journal-title":"Exp. Parasitol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent Antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.22533\/at.ed.1594872424095","article-title":"Clinical characterization and epidemiological aspects of human visceral leishmaniasis in the province of Salta\u2019. Period 2008 \u2013 2022","volume":"4","author":"Garc\u00eda Campos","year":"2024","journal-title":"Int. J. Health Sci."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12703\/r\/9-28","article-title":"An overview of the treatment of cutaneous leishmaniasis","volume":"9","author":"Garza-Tovar","year":"2020","journal-title":"Faculty Reviews"},{"key":"ref66","volume-title":"\u2018Global burden of disease study 2019\u2019 data resources","year":"2019"},{"key":"ref67","volume-title":"Global Health Observatory. Leishmaniasis","year":"2024"},{"key":"ref90030","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-3083.1995.tb03554.x","article-title":"\u2018Visceral leishmaniasis in vervet monkeys: immunological responses during asymptomatic infections\u2018","volume":"41","author":"Gicheru","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"ref68","first-page":"1136","article-title":"Climate change and vector-borne diseases: a regional analysis","volume-title":"Bull. World Health Organ","author":"Githeko","year":"2000"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1017\/S0031182012002156","article-title":"Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection","volume":"140","author":"Gomes-Silva","year":"2013","journal-title":"Parasitology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1371\/journal.pntd.0000585","article-title":"Climate change and risk of Leishmaniasis in North America: predictions from ecological niche models of vector and reservoir species","volume":"4","author":"Gonz\u00e1lez","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005067.pub3","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"Gonz\u00e1lez","year":"2008","journal-title":"Cochrane Library."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"983","DOI":"10.33218\/001c.90983","article-title":"\u2018A case of cutaneous leishmaniasis cured by a combined treatment of topical miltefosine and injectable amphotericin B\u2019, precision","volume":"6","author":"Guzman","year":"2023","journal-title":"Nanomedicine"},{"key":"ref74","volume-title":"Pentamidine","author":"Hafiz","year":"2023"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40121-020-00361-y","article-title":"Prevalence and risk factors of human Leishmaniasis in Ethiopia: a systematic review and Meta-analysis","volume":"10","author":"Haftom","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"ref9020","doi-asserted-by":"publisher","first-page":"1355044","DOI":"10.3389\/fddsv.2024.1355044","article-title":"The (misleading) role of animal models in drug development","volume":"4","author":"Hartung","year":"2024","journal-title":"Front. drug discov"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1002\/14651858.cd005067.pub5","article-title":"\u2018Interventions for Old World cutaneous leishmaniasis\u2019, Cochrane","volume":"2017","author":"Heras-Mosteiro","year":"2017","journal-title":"Library"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e0005424","DOI":"10.1371\/journal.pntd.0005424","article-title":"The global burden of disease study 2013: what does it mean for the NTDs?","volume":"11","author":"Herricks","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ijd.16407","article-title":"Topical liposomal amphotericin B gel treatment for cutaneous leishmaniasis caused by Leishmania major: a double-blind, randomized, placebo-controlled, pilot study","volume":"62","author":"Horev","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e0005581","DOI":"10.1371\/journal.pntd.0005581","article-title":"The rise of neglected tropical diseases in the \"new Texas\"","volume":"12","author":"Hotez","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-3024.1980.tb00061","article-title":"Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice","volume":"2","author":"Howard","year":"1980","journal-title":"Parasite Immunol."},{"key":"ref82","volume-title":"Global burden of disease 2021: Findings from the GBD 2021 study","year":"2024"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485905x16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran","volume":"99","author":"Iraji","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijpddr.2019.09.004","article-title":"Development of a topical liposomal formulation of amphotericin B for the treatment of cutaneous leishmaniasis","volume":"11","author":"Jaafari","year":"2019","journal-title":"Int. J. Parasitol. Drugs Resist."},{"key":"ref85","first-page":"653","volume-title":"Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. Geneva: World Health Organization","author":"Jain","year":"2024"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e2694","DOI":"10.1371\/journal.pntd.0002694","article-title":"Rapid healing of cutaneous Leishmaniasis by high-frequency Electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul","volume":"8","author":"Jebran","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2307\/3280894","article-title":"Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus)","volume":"69","author":"Jr","year":"1983","journal-title":"J. Parasitol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"104565","DOI":"10.1016\/j.etap.2024.104565","article-title":"Miltefosine induces reproductive toxicity during sperm capacitation by altering PI3K\/AKT signaling pathway","volume":"111","author":"Jung","year":"2024","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","article-title":"Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice","volume":"196","author":"Kavian","year":"2019","journal-title":"Acta Trop."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"111109","DOI":"10.1016\/j.biopha.2020.111109","article-title":"Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis","volume":"134","author":"Kawakami","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref9022","doi-asserted-by":"publisher","first-page":"126","DOI":"10.47176\/mjiri.38.126","article-title":"The Economic Burden of Cutaneous Leishmaniosis: Report from a Developing Country","volume":"38","author":"Khajedaluee","year":"2024","journal-title":"Med J Islam Repub Iran."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"658","DOI":"10.26719\/emhj.22.070","article-title":"Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran","volume":"28","author":"Khamesipour","year":"2022","journal-title":"East Mediterr. Health J."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11686-024-00899-8","article-title":"Identification of novel Antileishmanial Chemotypes by high-throughput virtual and in vitro screening","volume":"69","author":"Khan","year":"2024","journal-title":"Acta Parasitol."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/tropicalmed8040223","article-title":"A rare case of imported cutaneous leishmaniasis caused by Leishmania infantum in the Republic of Korea, 2021","volume":"8","author":"Kim","year":"2023","journal-title":"Trop Med Inf Dis"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.4269\/ajtmh.20-0107","article-title":"An atypical case of autochthonous cutaneous leishmaniasis associated with naturally infected phlebotomine sand flies in Texas, United States","volume":"103","author":"Kipp","year":"2020","journal-title":"Am J Trop. Med. Hygiene"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e1667","DOI":"10.1371\/journal.pntd.0001667","article-title":"Genetics of host response to Leishmania tropica in mice - different control of skin pathology, chemokine reaction, and invasion into spleen and liver","volume":"6","author":"Kobets","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1038\/s41598-017-13822-1","article-title":"Modeling the climatic suitability of leishmaniasis vector species in Europe","volume":"7","author":"Koch","year":"2017","journal-title":"Sci. Rep."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1007\/s00436-022-07681-7","article-title":"An experimental challenge model for Leishmania donovani in beagle dogs, showing a similar pattern of parasite burden in the peripheral blood and liver","volume":"121","author":"Konno","year":"2022","journal-title":"Parasitol. Res."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1017\/pao.2018.1","article-title":"Slow pace of antileishmanial drug development","volume":"4","author":"Kumar","year":"2018","journal-title":"Parasitology Open"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/ijd.IJD_602_20","article-title":"Post kala-azar dermal Leishmaniasis: clinical features and differential diagnosis","volume":"66","author":"Kumar","year":"2021","journal-title":"Indian J. Dermatol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/vaccines12101179","article-title":"Immunotherapeutic strategies as potential treatment options for cutaneous Leishmaniasis","volume":"12","author":"Lafleur","year":"2024","journal-title":"Vaccine"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2147\/rrtm.s24764","article-title":"\u2018Review of the current treatments for leishmaniases\u2019, research and reports","volume":"69","author":"Lauletta Lindoso","year":"2012","journal-title":"Tropical Medicine"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","article-title":"Efficacy of cryotherapy versus intralesional meglumine antimoniate (Glucantime) for treatment of cutaneous leishmaniasis in children","volume":"80","author":"Layegh","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/656523","article-title":"Efficacy of topical liposomal amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the treatment of cutaneous Leishmaniasis","volume":"2011","author":"Layegh","year":"2011","journal-title":"J. Parasitol. Res."},{"key":"ref105","volume-title":"BfArM Special Approval 91.1.07-5640-S-006\/16","year":""},{"key":"ref106","doi-asserted-by":"publisher","first-page":"e1552","DOI":"10.1016\/s2214-109x(24)00225-0","article-title":"Paving the way for affordable and equitable liposomal amphotericin B access worldwide","volume":"12","author":"Lee","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fcimb.2019.00228","article-title":"Post-kala-azar dermal Leishmaniasis as a reservoir for visceral Leishmaniasis transmission","volume":"9","author":"Le Rutte","year":"2019","journal-title":"Trends Parasitol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nrg1832","article-title":"Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis","volume":"7","author":"Lipoldov\u00e1","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"ref90040","volume-title":"Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Miltefosine","year":"2017"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44222-023-00063-3","article-title":"Human disease models in drug development","volume":"22","author":"Loewa","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/pathogens13080712","article-title":"In vivo evaluation of Sepigel-based meglumine antimoniate and amphotericin B for cutaneous leishmaniasis treatment","volume":"13","author":"L\u00f3pez-Arencibia","year":"2024","journal-title":"Pathogens"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7705\/biomedica.v36i2.2953","article-title":"Factores de riesgo en escenarios emergentes de leishmaniasis visceral urbana, Misiones, Argentina","volume":"36","author":"L\u00f3pez","year":"2016","journal-title":"Biomedica"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"e0006653","DOI":"10.1371\/journal.pntd.0006653","article-title":"A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia","volume":"12","author":"L\u00f3pez","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s0036-46652014000100001","article-title":"Animal models for the study of LEISHMANIASIS immunology","volume":"56","author":"Loria-Cervera","year":"2014","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1017\/S0031182022000828","article-title":"Ageing impairs protective immunity and promotes susceptibility to murine visceral leishmaniasis","volume":"149","author":"Loureiro Salgado","year":"2022","journal-title":"Parasitology"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e2465","DOI":"10.1093\/cid\/ciaa1337","article-title":"A double-blind, randomized trial to evaluate Miltefosine and topical granulocyte macrophage Colony-stimulating factor in the treatment of cutaneous Leishmaniasis caused by Leishmania braziliensis in Brazil","volume":"73","author":"Machado","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of cutaneous Leishmaniasis and insights into species-specific responses: a narrative review","volume":"11","author":"Madusanka","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e0011497","DOI":"10.1371\/journal.pntd.0011497","article-title":"The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005\u20132020","volume":"17","author":"Maia","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1021\/acsabm.9b00263","article-title":"Topically applied chitosan-coated poly(isobutylcyanoacrylate) nanoparticles are active against cutaneous Leishmaniasis by accelerating lesion healing and reducing the parasitic load","volume":"2","author":"Malli","year":"2019","journal-title":"ACS Applied Bio Materials"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11095-022-03232-y","article-title":"Current and future strategies against cutaneous parasites","volume":"39","author":"Man","year":"2022","journal-title":"Pharm. Res."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of Leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/microorganisms8111803","article-title":"Evaluation of a new topical treatment for the control of cutaneous Leishmaniasis","volume":"8","author":"Mart\u00ednez-Salazar","year":"2020","journal-title":"Microorganisms"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.jddst.2020.101664","article-title":"A review of current treatments strategies based on paromomycin for leishmaniasis","volume":"57","author":"Matos","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.onano.2023.100158","article-title":"Nanomaterials for diagnosis, treatment, and prevention of human cutaneous leishmaniasis: a review","volume":"12","author":"Maza Vega","year":"2023","journal-title":"OpenNano"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/jamadermatol.2018.2133","article-title":"Incidence of endemic human cutaneous leishmaniasis in the United States","volume":"154","author":"McIlwee","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijid.2020.11.183","article-title":"Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: a randomized and controlled trial","volume":"103","author":"Mendes","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"e1012598","DOI":"10.1371\/journal.ppat.1012598","article-title":"Saurian-associated Leishmania tarentolae in dogs: infectivity and immunogenicity evaluation in the canine model","volume":"20","author":"Mendoza-Roldan","year":"2024","journal-title":"PLoS Pathog."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","article-title":"U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref130","volume-title":"Recomendaciones para la prevenci\u00f3n de leishmaniasis canina","year":"2023"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical Imiquimod 5% with parenteral Meglumine Antimoniate in the treatment of cutaneous Leishmaniasis in Peru","volume":"40","author":"Miranda-Verastegui","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/tropicalmed2030036","article-title":"Neglected tropical diseases: epidemiology and global burden","volume":"2","author":"Mitra","year":"2017","journal-title":"Trop. Med. Inf. Dis."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis","volume":"58","author":"Mosleh","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"108942","DOI":"10.1016\/j.biopha.2019.108942","article-title":"Niosomal formulation of amphotericin B alone and in combination with glucantime: in vitro and in vivo leishmanicidal effects","volume":"116","author":"Mostafavi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/cid\/cix808","article-title":"Monitoring of parasite kinetics in Indian post-kala-azar dermal Leishmaniasis","volume":"66","author":"Moulik","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"e0011492","DOI":"10.1371\/journal.pntd.0011492","article-title":"Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers","volume":"17","author":"Mouri","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","article-title":"Tissue granuloma structure-function in experimental visceral leishmaniasis","volume":"82","author":"Murray","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"117109","DOI":"10.1016\/j.biopha.2024.117109","article-title":"Enhancing the efficacy of fluconazole against Leishmania major: formulation and evaluation of FLZ-nanoemulsions for topical delivery","volume":"178","author":"Nahanji","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.trstmh.2012.02.006","article-title":"Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia","volume":"106","author":"Negera","year":"2012","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jac\/dkz049","article-title":"Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis","volume":"74","author":"Neira","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0035-9203(97)90290-x","article-title":"Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin","volume":"91","author":"Neva","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-018-0355-8","article-title":"Microneedle-based delivery of amphotericin B for treatment of cutaneous leishmaniasis","volume":"21","author":"Nguyen","year":"2019","journal-title":"Biomed. Microdevices"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1038\/s41598-024-60883-0","article-title":"Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis","volume":"14","author":"Niroumand","year":"2024","journal-title":"Sci. Rep."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human Leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/tropicalmed8050275","article-title":"Alternative non-drug treatment options of the most neglected parasitic disease cutaneous leishmaniasis: a narrative review","volume":"8","author":"Orabi","year":"2023","journal-title":"Trop. Med. Inf. Dis."},{"key":"ref151","volume-title":"Directrices para el tratamiento de las leishmaniasis en la Regi\u00f3n de las Am\u00e9ricas","year":"2022"},{"key":"ref152","volume-title":"Cuatro pa\u00edses de Am\u00e9rica Latina usan termoterapia para tratar la leishmaniasis cut\u00e1nea en poblaciones vulnerables","year":"2023"},{"key":"ref153","volume-title":"PAHO Strategic Fund","year":""},{"key":"ref154","volume-title":"Leishmaniasis: epidemiological report for the Americas","year":""},{"key":"ref155","volume-title":"Cooperaci\u00f3n t\u00e9cnica en Per\u00fa para el tratamiento y vigilancia de la leishmaniasis","year":"2025"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/jac\/dkae129","article-title":"Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia","volume":"79","author":"Pali\u0107","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/iai.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect. Immun."},{"key":"ref9005","doi-asserted-by":"publisher","first-page":"e07136","DOI":"10.1016\/j.heliyon.2021.e07136","article-title":"\u2018Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis\u2018","volume":"7","author":"Peralta","year":"2021","journal-title":"Heliyon"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"e07136","DOI":"10.1016\/j.heliyon.2021.e07136","article-title":"Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis","volume":"7","author":"Peralta","year":"","journal-title":"Heliyon"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s13346-021-00896-8","article-title":"Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis","volume":"12","author":"Peralta","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fcimb.2019.00030","article-title":"Understanding resistance vs. susceptibility in visceral Leishmaniasis using mouse models of Leishmania infantum infection","volume":"9","author":"P\u00e9rez-Cabezas","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"065","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review","volume":"28","author":"Piccica","year":"2021","journal-title":"J. Travel Med."},{"key":"ref9026","doi-asserted-by":"publisher","first-page":"CD004834","DOI":"10.1002\/14651858.CD004834.pub3","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Pinart","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.trstmh.2005.11.005","article-title":"Leishmania infantum-induced primary and challenge infections in rhesus monkeys (Macaca mulatta): a primate model for visceral leishmaniasis","volume":"100","author":"Porrozzi","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1186\/s12889-015-2424-8","article-title":"Clinico-epidemiological analysis of post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study","volume":"15","author":"Ramesh","year":"2015","journal-title":"BMC Public Health"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/09546631003762654","article-title":"Liquid nitrogen cryotherapy on Leishmania donovani cutaneous leishmaniasis","volume":"22","author":"Ranawaka","year":"2011","journal-title":"J. Dermatolog. Treat."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1128\/aac.00628-13","article-title":"Pharmacokinetics and absorption of Paromomycin and gentamicin from topical creams used to treat cutaneous Leishmaniasis","volume":"57","author":"Ravis","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4269\/ajtmh.16-0879","article-title":"Efficacy, safety and cost-effectiveness of thermotherapy in the treatment of Leishmania donovani\u2013induced cutaneous Leishmaniasis: a randomized controlled clinical trial","volume":"97","author":"Refai","year":"2017","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1208\/s12249-020-01819-5","article-title":"Correction to: preparation and characterization of nanostructured lipid carriers for improved topical drug delivery: evaluation in cutaneous leishmaniasis and vaginal candidiasis animal models","volume":"21","author":"Riaz","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1128\/IAI.02083-14","article-title":"Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations","volume":"82","author":"Ribeiro-Rom\u00e3o","year":"2014","journal-title":"Infect. Immun."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.3791\/3533","article-title":"Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs","volume":"62","author":"Robledo","year":"2012","journal-title":"JoVE"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"e0007788","DOI":"10.1371\/journal.pntd.0007788","article-title":"\u201cCheaper and better\u201d: societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia","volume":"13","author":"Rodr\u00edguez","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"ii64","DOI":"10.1093\/inthealth\/ihac012","article-title":"How has the Ascend programme contributed to strengthening health systems for sustainable country-driven neglected tropical disease programming?","volume":"14","author":"Rowan","year":"2022","journal-title":"Int. Health"},{"key":"ref173","first-page":"471","article-title":"Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years\/surveillance mondiale de la leishmaniose, 2022: evaluation des tendances des 10 dernieres annees","volume":"98","author":"Ruiz-Postigo","year":"2023","journal-title":"Wkly Epidemiol. Rec."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am. J. Med."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7205\/MILMED-D-11-00161","article-title":"Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial","volume":"177","author":"Safi","year":"2012","journal-title":"Mil. Med."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12906-024-04522-1","article-title":"In vitro and in vivo anti-parasitic activity of curcumin nanoemulsion on Leishmania major (MRHO\/IR\/75\/ER)","volume":"24","author":"Sahebi","year":"2024","journal-title":"BMC Compl. Med. Ther."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"e2749","DOI":"10.1371\/journal.pntd.0002749","article-title":"Parasite load decrease during application of a safe and easily applied Antileishmanial aminoglycoside cream","volume":"8","author":"Salah","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"82810","DOI":"10.5812\/semj.82810","article-title":"Economic burden evaluation of cutaneous leishmaniasis in Iran","volume":"20","author":"Salimi","year":"2019","journal-title":"Shiraz E-Medical J."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"624009","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral Leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jaad.2020.08.043","article-title":"The global, regional, and national burden of leishmaniasis: an ecologic analysis from the global burden of disease study 1990-2017","volume":"84","author":"Scheufele","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bjd.18964","article-title":"American cutaneous leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate","volume":"183","author":"Senchyna","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref186","first-page":"42","article-title":"Efficacy of topical 5% imiquimod with cryotherapy versus intralesional meglumine antimoniate in the treatment of anthroponotic cutaneous leishmaniasis","volume":"14","author":"Shamsi Meymandi","year":"2011","journal-title":"Iranian J. Dermatol."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"e0290297","DOI":"10.1371\/journal.pone.0290297","article-title":"Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: in -vivo analysis","volume":"18","author":"Sharma","year":"2023","journal-title":"PLoS One"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"e0011635","DOI":"10.1371\/journal.pntd.0011635","article-title":"Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform","volume":"18","author":"Singh-Phulgenda","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/molecules25071741","article-title":"Efficacy of topical treatment with (\u2212)-epigallocatechin Gallate, a green tea Catechin, in mice with cutaneous Leishmaniasis","volume":"25","author":"Sosa","year":"2020","journal-title":"Molecules"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (Paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"Sosa","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"e0007253","DOI":"10.1371\/journal.pntd.0007253","article-title":"Topical paromomycin for New World cutaneous leishmaniasis","volume":"13","author":"Sosa","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/clinids\/20.1.47","article-title":"Successful treatment of New World cutaneous Leishmaniasis with a combination of topical Paromomycin\/Methylbenzethonium chloride and injectable Meglumine Antimonate","volume":"20","author":"Soto","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study","volume":"66","author":"Soto","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref195","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cid\/ciy619","article-title":"Topical 15% paromomycin-Aquaphilic for Bolivian Leishmania braziliensis cutaneous leishmaniasis: a randomized, placebo-controlled trial","volume":"68","author":"Soto","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/cid\/cir496","article-title":"High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis","volume":"53","author":"Sousa","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12879-014-0619-8","article-title":"A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan","volume":"14","author":"Stahl","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"ref200","doi-asserted-by":"publisher","first-page":"e0004560","DOI":"10.1371\/journal.pntd.0004560","article-title":"Between-country inequalities in the neglected tropical disease burden in 1990 and 2010, with projections for 2020","volume":"10","author":"Stolk","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"e000709","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine\u2014a life-saving drug for leishmaniasis\u2014is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"e029141","DOI":"10.1136\/bmjopen-2019-029141","article-title":"Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study","volume":"9","author":"Sunyoto","year":"2019","journal-title":"BMJ Open"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"e0155482","DOI":"10.1371\/journal.pone.0155482","article-title":"Cost of pediatric visceral Leishmaniasis Care in Morocco","volume":"11","author":"Tachfouti","year":"2016","journal-title":"PLoS One"},{"key":"ref204","volume-title":"Cost-effectiveness analysis of meglumine antimoniate versus sodium stibogluconate in the treatment of cutaneous leishmaniasis in Peru","author":"Tejada Caminiti","year":"2018"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.parint.2003.12.002","article-title":"Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis","volume":"53","author":"Terabe","year":"2004","journal-title":"Parasitol. Int."},{"key":"ref206","doi-asserted-by":"publisher","first-page":"e0012423","DOI":"10.1371\/journal.pntd.0012423","article-title":"The economic burden of visceral leishmaniasis and barriers to accessing healthcare in Tigray, North Ethiopia: a field based study","volume":"18","author":"Tessema","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref207","volume-title":"Getting photodynamic therapy","year":"2021"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","article-title":"Immune response to leishmania: paradox rather than paradigm","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref209","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/S1473-3099(23)00353-5","article-title":"\u2018The status of combination therapy for visceral leishmaniasis: an updated review\u2019","volume":"24","author":"Van Griensven","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref210","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1017\/S003118201600024X","article-title":"Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB\/c, BALB\/c nude and C57BL\/6 mice","volume":"143","author":"Velasquez","year":"2016","journal-title":"Parasitology"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1590\/0074-02760150381","article-title":"Spread of Phlebotominae in temperate climates: province of C\u00f3rdoba, Argentina","volume":"111","author":"Visintin","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"e0011752","DOI":"10.1371\/journal.pntd.0011752","article-title":"Ensuring access to essential health products: lessons from Colombia\u2019s leishmaniasis control and elimination initiative","volume":"17","author":"Vlassoff","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref213","article-title":"Control of the leishmaniases: WHO Tech. Rep. Ser. N\u00b0949","year":"2010"},{"key":"ref214","volume-title":"Post-kala-azar dermal leishmaniasis: a manual for case management and control","year":"2012"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3025185","article-title":"The economic impact of cutaneous leishmaniasis in Sri Lanka","volume":"2018","author":"Wijerathna","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref219","doi-asserted-by":"publisher","first-page":"108687","DOI":"10.1016\/j.exppara.2023.108687","article-title":"Dermal microdialysis: a method to determine drug levels in the skin of patients with post kala-azar dermal leishmaniasis (PKDL)","volume":"257","author":"Wijnant","year":"2024","journal-title":"Exp. Parasitol."},{"key":"ref216","first-page":"653","volume-title":"Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map. Geneva: World Health Organization","year":"2024"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaad.2007.11.008","article-title":"Cutaneous leishmaniasis in Texas: a northern spread of endemic areas","volume":"58","author":"Wright","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref221","doi-asserted-by":"publisher","first-page":"e0011780","DOI":"10.1371\/journal.pntd.0011780","article-title":"Safety and efficacy of paromomycin\/miltefosine\/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: a phase II, open label, randomized, parallel arm study","volume":"17","author":"Younis","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref224","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.4103\/amsr.amsr_53_24","article-title":"Post kala-azar dermal leishmaniasis in East Africa, with a focus on Sudan: review of three decades of experience and research","volume":"4","author":"Zijlstra","year":"2025","journal-title":"Annal. Med. Sci. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1588311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:01:39Z","timestamp":1768204899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1588311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":217,"alternative-id":["10.3389\/fmicb.2025.1588311"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1588311","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1588311"}}